Format

Send to

Choose Destination
Epigenomics. 2019 Mar 1. doi: 10.2217/epi-2018-0149. [Epub ahead of print]

Clinicopathological, immune and molecular correlates of PD-L2 methylation in gastric adenocarcinomas.

Author information

1
Department of Surgery, University Hospital Bonn, Bonn, Germany.
2
Department of Otolaryngology, Head & Neck Surgery, University Hospital Bonn, Bonn, Germany.

Abstract

AIM:

We investigated the significance of PD-L2 DNA methylation in gastric adenocarcinomas.

METHODS:

We analyzed the methylation at different CpG sites within the PD-L2-encoding gene PDCD1LG2 with regard to correlations and associations with gene expression, clinicopathological parameters, molecular features and immune cell infiltrates in two publicly available cohorts (The Cancer Genome Atlas and Singapore cohorts) of a total of 594 gastric adenocarcinoma patients.

RESULTS:

PD-L2 methylation is significantly associated with transcriptional activity, survival, Epstein-Barr virus infection, PD-L2 gene amplification, CD8+ T-cell infiltration, microsatellite instability and high mutational load (tumor mutational burden, hypermutation).

CONCLUSION:

PD-L2 methylation is associated with known predictive biomarkers of response to anti-PD-1 immunotherapies.

KEYWORDS:

; , Epstein–Barr virus; DNA methylation; biomarker; gastric cancer; hypermutation; immunotherapy; microsatellite instability

PMID:
30821175
DOI:
10.2217/epi-2018-0149

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center